Dr. Rona Lamiquiz is an associate in the San Francisco office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations practice. Rona's practice focuses on strategic patent counseling and monetization in the life sciences and biotechnology industries. In addition to patent prosecution and procurement, she has experience with intellectual property (IP) due diligence, freedom-to-operate analyses, and patent validity and infringement opinions. She also acquired IP litigation experience when she practiced as a litigator and participated in inter partes review (IPR) proceedings.
Rona has extensive knowledge relating to diverse technologies, including vaccines and antibodies, peptides sequencing and bioinformatics, biomarkers and diagnostic sciences, CRISPR-related technologies, stem cell culturing, among other technologies. While attending law school, she worked at Pfizer as a patent intern. As a graduate student, her research focused on insulin resistance mechanisms in skeletal muscle and adipose tissue.
Dr. Rona Lamiquiz is an associate in the San Francisco office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations practice. Rona's practice focuses on strategic patent counseling and monetization in the life sciences and biotechnology industries. In addition to patent prosecution and procurement, she has experience with intellectual property (IP) due diligence, freedom-to-operate analyses, and patent validity and infringement opinions. She also acquired IP litigation experience when she practiced as a litigator and participated in inter partes review (IPR) proceedings.
Rona has extensive knowledge relating to diverse technologies, including vaccines and antibodies, peptides sequencing and bioinformatics, biomarkers and diagnostic sciences, CRISPR-related technologies, stem cell culturing, among other technologies. While attending law school, she worked at Pfizer as a patent intern. As a graduate student, her research focused on insulin resistance mechanisms in skeletal muscle and adipose tissue.
- J.D., Sandra Day O'Connor College of Law, Arizona State UniversityRecipient, CALI Excellence in Biotechnology Licensing in Litigation; Diversity Legal Writing Scholarship; Dean's Recruitment Scholarship
- Ph.D., Molecular and Cellular Pathology School of Medicine, University of Alabama at BirminghamPathology Department Fellowship, Travel Awards—69th and 70th American Diabetes Association Scientific Sessions
- B.S., Agriculture, School of Agriculture, Yangzhou University, Yangzhou, Jiangsu Province, China
- Member, American Intellectual Property Law Association (AIPLA)
- State Bar of California
- Supreme Court of Arizona
- U.S. District Court for the District of Arizona
- U.S. Patent and Trademark Office
- J.D., Sandra Day O'Connor College of Law, Arizona State UniversityRecipient, CALI Excellence in Biotechnology Licensing in Litigation; Diversity Legal Writing Scholarship; Dean's Recruitment Scholarship
- Ph.D., Molecular and Cellular Pathology School of Medicine, University of Alabama at BirminghamPathology Department Fellowship, Travel Awards—69th and 70th American Diabetes Association Scientific Sessions
- B.S., Agriculture, School of Agriculture, Yangzhou University, Yangzhou, Jiangsu Province, China
- Member, American Intellectual Property Law Association (AIPLA)
- State Bar of California
- Supreme Court of Arizona
- U.S. District Court for the District of Arizona
- U.S. Patent and Trademark Office
Select Recent Publications
- Co-author with X. Wu, J. L. Franklin, J. L. Messina, H. S. Hill, D. R. Moellering, R. G. Walton, M. Martin, and W. T. Garvey, "Mammalian Tribbles Homolog 3 Impairs Insulin Action in Skeletal Muscle: Role in Glucose-Induced Insulin Resistance," 298(3) American Journal of Physiology-Endocrinology & Metabolism 565-576, 2010
- Co-author with W. Zhang, G. C. Chuang, H. S. Hill, L. Tian, D. R. Moellering, and W. T. Garvey, "Role of TRIB3 in Regulation of Insulin Sensitivity and Nutrient Metabolism during Short-term Fasting and Nutrient Excess," 303(7) American Journal of Physiology-Endocrinology & Metabolism 908-916, 2012
- Co-author with W. Zhang, L. Tian, Q. Liu, Y. Fu, and W. T. Garvey, "TRIB3 Mediates Glucose-Induced Insulin Resistance via a Mechanism that Requires the Hexosamine Biosynthetic Pathway," 62(12) Diabetes 4192-4200, 2013
Select Recent Publications
- Co-author with X. Wu, J. L. Franklin, J. L. Messina, H. S. Hill, D. R. Moellering, R. G. Walton, M. Martin, and W. T. Garvey, "Mammalian Tribbles Homolog 3 Impairs Insulin Action in Skeletal Muscle: Role in Glucose-Induced Insulin Resistance," 298(3) American Journal of Physiology-Endocrinology & Metabolism 565-576, 2010
- Co-author with W. Zhang, G. C. Chuang, H. S. Hill, L. Tian, D. R. Moellering, and W. T. Garvey, "Role of TRIB3 in Regulation of Insulin Sensitivity and Nutrient Metabolism during Short-term Fasting and Nutrient Excess," 303(7) American Journal of Physiology-Endocrinology & Metabolism 908-916, 2012
- Co-author with W. Zhang, L. Tian, Q. Liu, Y. Fu, and W. T. Garvey, "TRIB3 Mediates Glucose-Induced Insulin Resistance via a Mechanism that Requires the Hexosamine Biosynthetic Pathway," 62(12) Diabetes 4192-4200, 2013
- Privacy Policy
- Terms of Use
- Accessibility